RecruitingNot ApplicableNCT07158736

Genicular Nerve Block for Knee Pain in the ED

Ultrasound-Guided Genicular Nerve Block for Knee Pain in the Emergency Department: A Randomized Controlled Trial

Sponsor

University of Pennsylvania

Enrollment

34 participants

Start Date

Aug 6, 2025

Study Type

INTERVENTIONAL

Conditions

Knee pain

Summary

Patient with atraumatic knee pain without a large knee effusion on x-ray will be randomized to receive either a genicular nerve block (GNB) or standard of care in the emergency department.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Genicular nerve block with bupivacaine and corticosteroids and Standard of Care for people with knee pain. The study is currently recruiting participants at 4 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREGenicular nerve block with bupivacaine and corticosteroids

genicular nerve block with ideal body-weight dosing of bupivacaine 0.5% with 4 mg dexamethasone

OTHERStandard of Care

This involves standard of care pain relief for patients who do not receive the genicular nerve block for knee pain, such as acetaminophen, non-steroidal anti-inflammatory drugs (NSAIDs), and opioids.